2Stange, J, Mitzner S, Klammt S, et la. Inhibition of NO synthase by arginine removal by liver support (MARS)seems to be only a cofactor for reversal of hypotension in decompensated liver cirrhosis that seems to be linked more to removal of protein bound t
3Joly A, Desjardins JF, Fremond B, et al. Survivial, proliferation and functions of porcine hepatocytes encapsulated in coated alginate beads: a step toward a rellable bioartificial liver. Transplantation, 1997, 63 (6) :795-803.
4Mullen KD. Treatment of hepatorenal syndrome: lessons from the MARS trial. Hepatology, 2002, 35: 492-493.
5Mitzner SR, Stange J. Treatment of hepatorenal syndrome:lessons from the MARS trials. Hepatology, 2002,35 (2):492-293.
6Sorkine P, Abraham RB, Szold O. Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure.Crit Care Med, 2001, 29 (7) : 1332-1336.
7Koball S, Peszynki P, Freytag J, et al. Removal of albumin bound toxins with the MARS-system shows protective effects on hepatocytes. ASAIOL, 2000, 46: 239.
8Gerlach J, Ziemer R, Neuhaus P. Fulminant liver failure:relevance of extracorporeal hyhrid liver support systems. Iht J ArtifOrgans, 1996, 19 (1) :7-13.
7Koball S,Peszynki P,Freytag J,et al.Removal of albu2 min bound toxins with the MARS2system shows protective effects on hepatocytes1 ASAIOL.2000 ;46:2391.
8Stange J,Mitzner S,Klammt S.Inhibition of NO synthase by arginine removal by liver support(MARS)seems to be only a cofactor for reversal of hypotension in decompensated liver cirrhosis that seems to be linked more to removal of protein bound toxins.HEPATOLOGY.2000; 32:1812.
9Awad SS,Sawada S,Soldes OS,et al.Can the clearance of tumor necrosis factor alpha and interleukin 6 be enhanced using an albumin dialysate hemodiafiltration system? ASAIO J.1999;45(1):47-49.
10Majcher-Peszynska,J,Hehl EM,Wacke R,et al.Removal of Diazepam as a marker molecule for Benzodiazepine-like substances(BLS)during albumin dialysis.Clin Pharmacology.1999:55:A26.
